Related Experiment Video
Updated: Jul 14, 2026

06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
[Cardiovascular autonomic dysfunction in experimental diabetes mellitus]
Katia De Angelis1, Beatriz D'Agord Schaan, Bruno Rodrigues
1Universidade São Judas Tadeu, Brazil.
Arquivos Brasileiros De Endocrinologia E Metabologia
|May 17, 2007
Summary
Diabetic cardiovascular autonomic dysfunction is a severe complication in animal models. This review highlights how studies using rodent models advance understanding, treatment, and prevention strategies for this condition.
Area of Science:
- Cardiovascular physiology
- Endocrinology
- Autonomic nervous system research
Context:
- Recent research has illuminated the pathophysiology of cardiovascular autonomic dysfunction in diabetic animal models.
- Experimental diabetes in rodents consistently demonstrates severe autonomic dysfunction.
- Understanding these models is crucial for translating findings to human diabetic complications.
Purpose:
- To review the contributions of animal model studies to understanding diabetic cardiovascular autonomic dysfunction.
- To explore how these models aid in developing treatments and preventative measures.
- To synthesize current knowledge on insulin deficiency/resistance models and their impact on autonomic function.
Summary:
- This manuscript reviews studies on experimental diabetes in rodent models, focusing on cardiovascular autonomic dysfunction.
- Evidence shows significant dysautonomia in these models, providing insights into pathophysiology.
- The review consolidates findings from various insulin deficiency and resistance models.
Impact:
- Advances the understanding of diabetic cardiovascular autonomic dysfunction mechanisms.
- Provides a foundation for developing novel therapeutic and preventative strategies.
- Highlights the critical role of animal models in biomedical research for diabetes complications.
More Related Videos
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

